Results 321 to 330 of about 1,436,444 (347)

Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice

Molecular Therapy, 2018
Michael C Jensen, Jeffrey S. Miller, Jakub Tolar   +2 more
exaly  

Targeting Primary Pre-B Cell Acute Lymphoblastic Leukemia and CD19-Negative Relapses Using Trivalent CAR T Cells

, 2017
Kristen Fousek, Junji Watanabe, Ann George, Xingyue An, H. Samaha, Shoba A. Navai, T. Byrd, Albert Jang, Hye Na Kim, Sujith K. Joseph, M. Baker, N. Varadarajan, M. Hegde, Yong-Mi Kim, N. Heisterkamp, H. Abdel-Azim, N. Ahmed   +16 more
semanticscholar   +1 more source

Diphtheria toxin-based anti-human CD19 immunotoxin for targeting human CD19+ tumors

Molecular Oncology, 2017
David H Sachs, Christene A Huang, Zhirui Wang   +2 more
exaly  

CHIMERIC ANTIGEN RECEPTORS TARGETING CD37 AND CD19

2021
openaire   +2 more sources

Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis

Cell
Lingying Ye, Hongjuan Lu, Na Ta
exaly  

Role of CD19 signal transduction in B cell biology

Immunologic Research, 2002
Robert H Carter
exaly  

Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient mice

Nature, 1995
R. Rickert, K. Rajewsky, J. Roes
semanticscholar   +1 more source

BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 AND CD20

2016
CHEN YVONNE Y, ZAH EUGENIA, JENSEN MICHAEL C   +2 more
openaire   +9 more sources

CD19 as an attractive target for antibody-based therapy

MAbs, 2012
exaly  

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

Molecular Therapy, 2017
Tanya Siddiqi, Nancy L Bartlett, Armin Ghobadi   +2 more
exaly